Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis

Frontiers in Medicine

Volumn 1, Issue DEC, 2014, Pages

  Moore, Bethany B ^a,b   Fry, Chris ^a   Zhou, Yueren ^b   Murray, Susan ^b   Han, MeiLan K ^a,b   Martinez, Fernando J ^b,c   Flaherty, Kevin R ^a,b   Dushay, Kevin ^d   Kurtis, Jonathon ^e   Chapman, Jeffrey T ^f   Anstrom, Kevin ^f   Brown, Kevin K ^g   Cosgrove, Gregory ^g   Solomon, Joshua ^g   Swigris, Jeffrey ^g   Fernandez Perez, Evans ^g   Criner, Gerard ^h   Cordova, Francis ^h   Patel, Namrata ^h   Rogers, Thomas ^g   Belperio, John ⁱ   King, Talmadge E ^j   Collard, Harold R ^j   Noth, Imre ^k   Brown, Cathy ^k   Garcia, Joe G N ^k   Kyle Hogarth, D ^k   Huang, Yong ^k   Lussier, Yves ^k   Ma, Shwu Fan ^k   Wade, Michael ^k   Toews, Galen B ^b   White, Eric S ^b   Hogaboam, Cory ^b   Lama, Vibha ^b   Moore, Thomas ^b   Spino, Cathie ^b   Loyd, James E ^l   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BROWN UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f DUKE UNIVERSITY   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h TEMPLE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

^l VANDERBILT UNIVERSITY   (United States)

more..

Author keywords

Interstitial lung disease; Lung; Lymphocyte; Monocyte; Peripheral blood

Indexed keywords

EID: 84947948834     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00056     Document Type: Article

References (32)

1. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res (2002) 3:3. doi:10.1186/rr188
2. Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis: an integral model. Am J Respir Crit Care Med (2014) 189(10):1161-72. doi:10.1164/rccm.201312-2221PP
3. Naik PK, Moore BB. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med (2010) 4:759-71. doi:10.1586/ers.10.73
4. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J (2005) 25:528-33. doi:10.1183/09031936.05.00071004
5. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 176:1026-34. doi:10.1164/rccm.200702-326OC
6. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 366:1968-77. doi:10.1056/NEJMoa1113354
7. Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One (2010) 5:e8959. doi:10.1371/journal.pone.0008959
8. Feghali-Bostwick CA, Tsai CG, Valentine VG, Kantrow S, Stoner MW, Pilewski JM, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol (2007) 179:2592-9. doi:10.4049/jimmunol.179.4.2592
9. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med (2013) 5:205ra136. doi:10.1126/scitranslmed.3005964
10. Reilkoff RA, Peng H, Murray LA, Peng X, Russell T, Montgomery R, et al. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-beta1-induced pulmonary fibrosis. Am J Respir Crit Care Med (2013) 187:180-8. doi:10.1164/rccm.201206-1109OC
11. Galati D, De Martino M, Trotta A, Rea G, Bruzzese D, Cicchitto G, et al. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients. Cytokine (2014) 66:119-26. doi:10.1016/j.cyto.2013.12.003
12. Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E, Steiropoulos P, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 179:1121-30. doi:10.1164/rccm.200812-1936OC
13. Shimizu Y, Dobashi K, Endou K, Ono A, Yanagitani N, Utsugi M, et al. Decreased interstitial FOXP3(+) lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis. Int J Immunopathol Pharmacol (2010) 23:449-61
14. Campbell JD, HayGlass KT. T cell chemokine receptor expression in human Th1-and Th2-associated diseases. Arch Immunol Ther Exp (Warsz) (2000) 48:451-6
15. Yoshinouchi T, Naniwa T, Shimizu S, Ohtsuki Y, Fujita J, Sato S, et al. Expression of chemokine receptors CXCR3 and CCR4 in lymphocytes of idiopathic nonspecific interstitial pneumonia. Respir Med (2007) 101:1258-64. doi:10.1016/j.rmed.2006.10.019
16. Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic targeting of IL-4-and IL-13-responsive cells in pulmonary fibrosis. Immunol Res (2004) 30:339-49. doi:10.1385/IR:30:3:339
17. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 214:199-210. doi:10.1002/path.2277
18. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19:71-82. doi:10.1016/S1074-7613(03)00174-2
19. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 27:669-92. doi:10.1146/annurev.immunol.021908.132557
20. Gibbons MA, Mackinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med (2011) 184:569-81. doi:10.1164/rccm.201010-1719OC
21. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol (2001) 69:11-20. Available from: http://www.jleukbio.org/content/69/1/11.long
22. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol (2007) 178:2000-7. doi:10.4049/jimmunol.178.4.2000
23. Desai B, Mattson J, Paintal H, Nathan M, Shen F, Beaumont M, et al. Differential expression of monocyte/macrophage-selective markers in human idiopathic pulmonary fibrosis. Exp Lung Res (2011) 37:227-38. doi:10.3109/01902148.2010.538132
24. Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 303:L1046-56. doi:10.1152/ajplung.00139.2012
25. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS, Hesson DP, et al. Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One (2010) 5:e9683. doi:10.1371/journal.pone.0009683
26. Murray LA, Chen Q, Kramer MS, Hesson DP, Argentieri RL, Peng X, et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int J Biochem Cell Biol (2011) 43:154-62. doi:10.1016/j.biocel.2010.10.013
27. Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med (2014) 2:548-56. doi:10.1016/S2213-2600(14)70069-4
28. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest (1998) 101:746-54. doi:10.1172/JCI1422
29. Jiang D, Liang J, Hodge J, Lu B, Zhu Z, Yu S, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest (2004) 114:291-9. doi:10.1172/JCI200416861
30. Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M, Balbi B, et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med (2006) 173:310-7. doi:10.1164/rccm.200502-244OC
31. Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol (2010) 137:89-101. doi:10.1016/j.clim.2010.06.017
32. Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK, et al. Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2014). doi:10.1164/rccm.201407-1287OC